Janux Therapeutics Inc's total assets for Q1 2026 were $1.03B, an increase of 2.05% from the previous quarter. JANX total liabilities were $86.69M for the fiscal quarter, a 70.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.